These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 17514873)
1. Cardiac glycosides in cancer research and cancer therapy. Winnicka K; Bielawski K; Bielawska A Acta Pol Pharm; 2006; 63(2):109-15. PubMed ID: 17514873 [TBL] [Abstract][Full Text] [Related]
2. Novel therapeutic applications of cardiac glycosides. Prassas I; Diamandis EP Nat Rev Drug Discov; 2008 Nov; 7(11):926-35. PubMed ID: 18948999 [TBL] [Abstract][Full Text] [Related]
3. Digitoxin inhibits the growth of cancer cell lines at concentrations commonly found in cardiac patients. López-Lázaro M; Pastor N; Azrak SS; Ayuso MJ; Austin CA; Cortés F J Nat Prod; 2005 Nov; 68(11):1642-5. PubMed ID: 16309315 [TBL] [Abstract][Full Text] [Related]
4. Cardiac glycosides as novel cancer therapeutic agents. Newman RA; Yang P; Pawlus AD; Block KI Mol Interv; 2008 Feb; 8(1):36-49. PubMed ID: 18332483 [TBL] [Abstract][Full Text] [Related]
5. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers. Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333 [TBL] [Abstract][Full Text] [Related]
6. Digitoxin is a potential anticancer agent for several types of cancer. Haux J Med Hypotheses; 1999 Dec; 53(6):543-8. PubMed ID: 10687899 [TBL] [Abstract][Full Text] [Related]
7. Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells. Marín YE; Wall BA; Wang S; Namkoong J; Martino JJ; Suh J; Lee HJ; Rabson AB; Yang CS; Chen S; Ryu JH Melanoma Res; 2007 Oct; 17(5):274-83. PubMed ID: 17885582 [TBL] [Abstract][Full Text] [Related]
9. The role of nuclear factor kappaB in pancreatic cancer and the clinical applications of targeted therapy. Holcomb B; Yip-Schneider M; Schmidt CM Pancreas; 2008 Apr; 36(3):225-35. PubMed ID: 18362834 [TBL] [Abstract][Full Text] [Related]
10. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth. Sakamoto K; Maeda S; Hikiba Y; Nakagawa H; Hayakawa Y; Shibata W; Yanai A; Ogura K; Omata M Clin Cancer Res; 2009 Apr; 15(7):2248-58. PubMed ID: 19276252 [TBL] [Abstract][Full Text] [Related]
11. Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials. Slingerland M; Cerella C; Guchelaar HJ; Diederich M; Gelderblom H Invest New Drugs; 2013 Aug; 31(4):1087-94. PubMed ID: 23748872 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of NF-kappaB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate. Ma G; Tabanca N; Husnu Can Baser K; Kirimer N; Pasco DS; Khan IA; Khan SI Cancer Chemother Pharmacol; 2009 Mar; 63(4):673-80. PubMed ID: 18597088 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of export of fibroblast growth factor-2 (FGF-2) from the prostate cancer cell lines PC3 and DU145 by Anvirzel and its cardiac glycoside component, oleandrin. Smith JA; Madden T; Vijjeswarapu M; Newman RA Biochem Pharmacol; 2001 Aug; 62(4):469-72. PubMed ID: 11448457 [TBL] [Abstract][Full Text] [Related]
15. Digitoxin, at concentrations commonly found in the plasma of cardiac patients, antagonizes etoposide and idarubicin activity in K562 leukemia cells. López-Lázaro M; Pastor N; Azrak SS; Ayuso MJ; Cortés F; Austin CA Leuk Res; 2006 Jul; 30(7):895-8. PubMed ID: 16387358 [TBL] [Abstract][Full Text] [Related]
16. Tissue transglutaminase-mediated chemoresistance in cancer cells. Verma A; Mehta K Drug Resist Updat; 2007; 10(4-5):144-51. PubMed ID: 17662645 [TBL] [Abstract][Full Text] [Related]
17. Cardiac glycosides inhibit cancer through Na/K-ATPase-dependent cell death induction. Geng X; Wang F; Tian D; Huang L; Streator E; Zhu J; Kurihara H; He R; Yao X; Zhang Y; Tang J Biochem Pharmacol; 2020 Dec; 182():114226. PubMed ID: 32976831 [TBL] [Abstract][Full Text] [Related]
18. Preclinical anticancer activity of the specific endothelin A receptor antagonist ZD4054. Growcott JW Anticancer Drugs; 2009 Feb; 20(2):83-8. PubMed ID: 19065106 [TBL] [Abstract][Full Text] [Related]
19. High-throughput screening identifies cardiac glycosides as potent inhibitors of human tissue kallikrein expression: implications for cancer therapies. Prassas I; Paliouras M; Datti A; Diamandis EP Clin Cancer Res; 2008 Sep; 14(18):5778-84. PubMed ID: 18794087 [TBL] [Abstract][Full Text] [Related]
20. From Na+/K+-ATPase and cardiac glycosides to cytotoxicity and cancer treatment. Babula P; Masarik M; Adam V; Provaznik I; Kizek R Anticancer Agents Med Chem; 2013 Sep; 13(7):1069-87. PubMed ID: 23537048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]